Management

Below you will find the latest clinical articles covering .
Primary care nurses are at the forefront of and need to stay abreast of all the latest practice and treatment updates as their interaction with patients continuously evolves.

Insulin degludec (IDeg), a long-acting basal insulin, is cost-effective compared to insulin glargine U100 (IGlar), according to an economic analysis of two phase III clinical studies that was sponsored by Novo Nordisk and presented at the Diabetes UK Professional Conference

Newsletter

Sign up to the newsletter

Communication Preferences:

To understand how we process, use & safeguard your data, please see our Privacy Policy

Thank you for registering for Independent Nurse. In addition to this service, Independent Nurse and other parts of the Mark Allen Group may like to contact you about related products, events, surveys, special offers and services that we think you might enjoy. If you would prefer not to receive these communications, please indicate by ticking the boxes: Do Not contact by email Do Not contact by post Do Not contact by telephone

From time-to-time we would like to contact you with business focused messages, special offers and information from other partner organisations that we think may be of interest to you. These will always be relevant and you can opt out at any time. If you would prefer not to receive communications of this nature, please indicate: Do Not contact by email Do Not contact by post Do Not contact by telephone